Molecure SA (MOCP)

Warsaw
16.48
-0.32(-1.90%)
  • Volume:
    6,135
  • Bid/Ask:
    16.48/16.70
  • Day's Range:
    16.38 - 17.18
Earnings results expected in 13 days

MOCP Overview

Prev. Close
16.8
Day's Range
16.38-17.18
Revenue
1.95M
Open
17.18
52 wk Range
12.04-47.7
EPS
-1.06
Volume
6,135
Market Cap
231.21M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
15,957
P/E Ratio
-16.50
Beta
2.79
1-Year Change
-63.16%
Shares Outstanding
14,030,000
Next Earnings Date
Aug 31, 2022
What is your sentiment on Molecure?
or
Market is currently closed. Voting is open during market hours.

Molecure SA Company Profile

Molecure SA Company Profile

Employees
85
Market
Poland
  • Type:Equity
  • Market:Poland
  • ISIN:PLONCTH00011

Molecure S.A., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of neoplastic and inflammatory diseases in Poland. It is involved in the development of OATD-01, a chitotriosidase/acidic mammalian chitinase inhibitor that has completed phase I clinical trial for the treatment of idiopathic pulmonary fibrosis and sarcoidosis; YKL-40 program for the treatment of cancer and fibrosis; OATD-02 for the treatment of cancer; and Deubiquitinase program. The company was formerly known as OncoArendi Therapeutics S.A. and changed its name to Molecure S.A. in March 2022. Molecure S.A. was founded in 2012 and is headquartered in Warsaw, Poland.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellNeutralStrong Sell
SummaryStrong SellStrong SellStrong SellSellStrong Sell